NEW YORK, April 1 (Reuters) - Dozens of major companies and specialty brands that are not official Olympics sponsors have applied to run advertising campaigns featuring athletes ahead of the Rio 2016 Olympic Games, taking advantage of new rules that are shaking up the business of marketing surrounding the event.
Read more
Thursday, March 31, 2016
Australia shares hit one-month lows, NZ slips
SYDNEY/WELLINGTON, April 1 (Reuters) - Australian shares fell to their lowest in a month on Friday as bank stocks came under renewed pressure, while the New Zealand market snapped a run of record highs.
Read more
Read more
Alibaba scraps plan to inject pharmacy business in healthcare affiliate
SHANGHAI, April 1 (Reuters) - Chinese e-commerce giant Alibaba Group Holding Ltd has scrapped plans to inject its pharmacy business into a Hong Kong-listed affiliate, citing regulatory uncertainties over the deal as well as over China's broader healthcare industry.
Read more
Read more
Teva and Takeda name pharma veteran as CEO of Japan joint venture
March 31 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd and Japan's Takeda Pharmaceutical Co Ltd named Hiroshi Matsumori on Thursday as the chief executive of their new joint venture in Japan.
Read more
Read more
U.S., Canada issue joint alert on 'ransomware' after hospital attacks
March 31 (Reuters) - The United States and Canada on Thursday issued a rare joint cyber alert, warning against a recent surge in extortion attacks that infect computers with viruses known as "ransomware," which encrypt data and demand payments for it to be unlocked.
Read more
Read more
PRESS DIGEST- British Business - April 1
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Read more
Read more
BRIEF-Cardiovascular Systems says expects revenue to range from $43.5 mln to $44 mln for qtr
* Cardiovascular Systems Reports Stronger Than Expected Preliminary Fiscal Third-Quarter revenue
Read more
Read more
UPDATE 1-Third Point, Jana gain in March, Greenlight Capital flat
BOSTON, March 31 (Reuters) - Billionaire hedge fund investors Daniel Loeb and Barry Rosenstein made money in March when the stock market came back with stronger gains, but both men's funds are still in the red for the year, sources familiar with their performance said.
Read more
Read more
BRIEF-Nightingale Informatix announces refinancing of senior debt
* Nightingale announces refinancing of senior debt and issuance of convertible debenture Source text for Eikon: Further company coverage: (Bengaluru Newsroom)
Read more
Read more
BRIEF-Hansen Medical to restate financial statements for three, six months ended June 30, 2015
* On March 25, 2016, audit committee of board determined co will be required to restate financial statements for three,six months ended June 30, 2015
Read more
Read more
BRIEF-Endo International Plc says FTC's case is "without merit"
* Endo International PLC says FTC's case is "without merit" and Endo intends to "vigorously" defend itself in litigation
Read more
Read more
Pfizer says press release on drug pricing fake
March 31 (Reuters) - Pfizer Inc said a press release on drug pricing issued earlier on Thursday was fake and falsely attributed to the drugmaker.
Read more
Read more
BRIEF-Immucell enters into agreements covering certain credit facilities with TD Bank
* On march 28, 2016, co entered into agreements covering certain credit facilities with td bank n.a. In amount of up to $4.5 million - sec filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
UPDATE 2-WHO sees scientific consensus on Zika as cause for disorders
* Six countries have reported Zika sexual transmission (Recasts, adds fresh details from WHO statement)
Read more
Read more
BRIEF-Edwards Lifesciences CEO's 2015 total compensation was $9.1 mln vs $8.6 mln in 2014 - SEC Filing
* Says CEO Michael Mussallem's 2015 total compensation was $9.1 million versus $8.6 million in 2014 - sec filing Source text for Eikon: (http://1.usa.gov/1SpQhLv) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
BRIEF-Kalobios Pharmaceuticals files Non-Timely 10-K
* "Company's restructuring program places enormous strain on its limited human and financial resources" - SEC filing
Read more
Read more
U.S. study may point the way on how to beat the Zika virus
CHICAGO, March 31 (Reuters) - A molecular map of Zika has revealed important structural differences on a key protein of the virus that may explain why the pathogen attacks nerve cells while other viruses in the same family do not, U.S. researchers said on Thursday.
Read more
Read more
"Strong scientific consensus" emerges on Zika link to disorders - WHO
GENEVA, March 31 (Reuters) - Researchers are now convinced that the Zika virus is linked to microcephaly in babies and to Guillain-Barre, a rare neurological disorder that can weaken the muscles and cause paralysis, the World Health Organization (WHO) said on Thursday.
Read more
Read more
UPDATE 2-U.S. FTC sues drugmaker Endo over "pay-for-delay" deals
March 31 (Reuters) - The U.S. Federal Trade Commission said on Thursday it had filed a lawsuit accusing Endo International Plc of violating antitrust laws by striking "pay-for-delay" deals to block access to generic copies of its pain drugs.
Read more
Read more
RPT-UPDATE 2-Regulator orders drugmaker Valeant management to cease trading
March 31 (Reuters) - Valeant Pharmaceuticals International Inc's directors and key officers have received a cease-trade order by the securities regulator in the Canadian province of Quebec, on the company's request, Valeant said on Thursday.
Read more
Read more
BRIEF-Atricure Inc's CEO Michael Carrel's total compensation for 2015 was $4.8 mln vs total compensation of $6.5 mln in 2014
* CEO Michael Carrel total compensation for 2015 was $4.8 million versus total compensation of $6.5 million in 2014 - SEC FILING
Read more
Read more
UPDATE 1-Valeant directors, CEO ordered to cease trading shares
March 31 (Reuters) - Valeant Pharmaceuticals International Inc's directors and key officers have received a cease-trade order by the securities regulator in the Canadian province of Quebec, on the company's request, Valeant said on Thursday.
Read more
Read more
BRIEF-India's Alkem says UK-MHRA made eight observations after inspection at Tajola plant
* UK-MHRA has made eight observations after inspection at co's Tajola bioequivalent facility
Read more
Read more
BRIEF-Neuron Bio's capital increase is subscribed at 1.0 mln euros
* Says its capital increase was subscribed for in the total amount of 1.0 million euros ($1.1 million)
Read more
Read more
FEATURE-U.S. conservatives push for nearly unthinkable death penalty ban
AUSTIN, Texas, March 31 (Reuters) - A former gun industry lobbyist and budget-hawk Republicans are leading what might seem to be an unlikely hard-right campaign - trying to sway conservatives in places like Utah and Kansas that they should be the first Republican-held state in four decades to ban the death penalty.
Read more
Read more
U.S. FTC sues Endo for violating antitrust laws
March 31 (Reuters) - The U.S. Federal Trade Commission said it filed a complaint in a district court accusing some drugmakers, including Endo International Plc, of violating antitrust laws by striking deals to block consumers' access to generic copies of their drugs.
Read more
Read more
UPDATE 1-GlaxoSmithKline promises reduced drug patents to help world's poor
* GSK plans to pool patents on next-generation cancer drugs (Adds reaction, CEO comment on profits, country details)
Read more
Read more
BRIEF-Selvita signs another deal with Merck KGaA
* Signs another deal with Merck KGaA for the development and commercialization of oncological terapeutical molecules developed by Selvita as a part of its cancer metabolism platform
Read more
Read more
Genfit plans to test its drug in second liver disease
NEW YORK, March 31 (Reuters) - French drugmaker Genfit SA on Thursday said it would begin a midstage trial this year of its experimental drug elafibranor to treat primary biliary cholangitis, a chronic disease in which bile ducts in the liver are gradually destroyed.
Read more
Read more
RPT-Turkish health ministry says investigating drugmaker over bribe allegations
ISTANBUL, March 31 (Reuters) - Turkey's health ministry said on Thursday it has launched an investigation into allegations a drugmaker secured $85 million in business advantages through bribery.
Read more
Read more
BRIEF-Alkermes says study on extended-release naltrexone in opioid-dependent patients published in New England Journal Of Medicine
* Study on extended-release naltrexone in opioid-dependent patients involved in criminal justice system published in New England Journal Of Medicine
Read more
Read more
Deals of the day- Mergers and acquisitions
March 31 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday:
Read more
Read more
Italy police arrest suspected "hospital ward" serial killer
ROME, March 31 (Reuters) - A woman suspected of murdering 13 patients in a Tuscan hospital in 2014 and 2015 has been arrested, Italian police said in a statement on Thursday.
Read more
Read more
BRIEF-Brighter FY operating loss narrows to SEK 11.4 million
* FY operating revenue 15.7 million Swedish crowns ($1.93 million) versus 13.8 million crowns year ago
Read more
Read more
BRIEF-Biokhimik FY 2015 net result to RAS turns to profit of RUB 55.2 mln
* FY 2015 revenue to Russian Accounting Standards (RAS) of 1.70 billion roubles ($25.05 million) versus 1.13 billion roubles year ago
Read more
Read more
Wednesday, March 30, 2016
Swiss stocks - Factors to watch on March 31
ZURICH, March 31 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Thursday.
Read more
Read more
PRESS DIGEST- New York Times business news - March 31
March 31 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
Read more
Read more
Britain to ship record amount of nuclear waste to US -UK govt source
LONDON, March 31 (Reuters) - Britain will ship 700 kilograms of nuclear waste to the United States under a deal to be announced by Prime Minister David Cameron at a nuclear security summit in Washington on Thursday, a British government source said.
Read more
Read more
Decline in financial settlements with U.S. Big Pharma -report
WASHINGTON, March 31 (Reuters) - The amount of money big U.S. pharmaceutical manufacturers have paid to settle charges for violating federal health care laws has declined sharply in recent years, prompting a non-profit watchdog group to call for an increase in enforcement efforts.
Read more
Read more
BRIEF-Dynavax announces FDA acceptance for review of Biologics License Application and PDUFA action date for HEPLISAV-b(tm)
* Dynavax announces FDA acceptance for review of Biologics License Application and PDUFA action date for HEPLISAV-b(tm) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
Read more
Read more
Early ultrasounds may not detect microcephaly in mothers with Zika - study
CHICAGO, March 30 (Reuters) - Three ultrasounds done in the early weeks of pregnancy in a Finnish woman living in the United States infected by Zika failed to show signs of brain damage in a fetus later diagnosed with the birth defect microcephaly, U.S. researchers said in a study published on Wednesday.
Read more
Read more
UPDATE 1-Medivation working with JPMorgan on takeover approaches -sources
March 30 (Reuters) - Medivation Inc has been working with investment JPMorgan Chase & Co to handle interest from other companies in a potential acquisition, but it has no plans to sell itself, according to people familiar with the matter.
Read more
Read more
BRIEF-Rxi Pharmaceuticals reports Q4 loss per share of $0.04
* Rxi pharmaceuticals reports fourth quarter and year end 2015 financial results and recent corporate highlights
Read more
Read more
UPDATE 1-US agency backs expanded use of medical abortion pill
WASHINGTON, March 30 (Reuters) - The U.S. Food and Drug Administration on Wednesday agreed to allow more access to Danco Laboratories' abortion pill Mifeprex, likely making it easier and cheaper for women to have an abortion by medication.
Read more
Read more
Republican Trump says women should be punished for illegal abortions
WASHINGTON, March 30 (Reuters) - U.S. Republican presidential front-runner Donald Trump said on Wednesday that women should face punishment if they receive abortions if the procedure is made illegal.
Read more
Read more
SEC fines, bans San Francisco biotech capitalist for theft
March 30 (Reuters) - A San Francisco biotechnology venture capitalist agreed to pay nearly $5.8 million to settle U.S. Securities and Exchange Commission charges he stole investor money to pay for vacations in St. Bart's and Paris, Tiffany jewelry, private jets and other expenses.
Read more
Read more
UPDATE 1-Rare liver disorder drug from Jazz wins U.S. approval
March 30 (Reuters) - The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.
Read more
Read more
Pfizer, Allergan get request for additional information from FTC
March 30 (Reuters) - Pfizer Inc and Allergan Plc said they have received a request for additional information from the U.S. Federal Trade Commission with respect to their merger.
Read more
Read more
Jazz Pharmaceuticals' rare liver disorder drug wins U.S. approval
March 30 (Reuters) - The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.
Read more
Read more
BRIEF-U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
* U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
Read more
Read more
UPDATE 2-Valeant seeks lender approval to extend deadline for annual report
March 30 (Reuters) - Valeant Pharmaceuticals International Inc said it was asking its lenders to extend until May 31 the deadline for it to file its annual report, lessening the chance of a default on its $30 billion debt if it misses the current deadline of April 29.
Read more
Read more
FDA permits use of test to screen donated blood for Zika
March 30 (Reuters) - The U.S. Food and Drug Administration said it would allow the use of an experimental test to screen donated blood for the Zika virus.
Read more
Read more
Deals of the day- Mergers and acquisitions
March 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Wednesday:
Read more
Read more
BRIEF-Contravir pharmaceuticals announces pricing of underwritten public offering
* Contravir pharmaceuticals Inc pricing underwritten public offering of common stock and warrants to purchase common stock
Read more
Read more
BRIEF-Oxigene receives fast track status from U.S. FDA for CA4P
* Oxigene receives fast track designation from U.S. FDA for CA4P Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
BRIEF-Adaptimmune Therapeutics says FDA grants orphan drug designation to its t-cell therapy
* U.S. Food and drug administration grants orphan drug designation to adaptimmune's t-cell therapy targeting ny-eso for treatment of soft tissue sarcoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
Read more
Read more
UPDATE 1-State Street to buy GE Asset Management for up to $485 mln
March 30 (Reuters) - State Street Corp said it would buy General Electric Co's asset management business for up to $485 million as the industrial conglomerate winds down its financing arm to reduce regulatory burden.
Read more
Read more
BRIEF-OPKO receives complete response letter from FDA for Rayaldee new drug application
* Opko Health Inc - Opko receives complete response letter from fda for rayaldee new drug application
Read more
Read more
BRIEF-Epigenomics enters agreement with Biochain on lung cancer test for China
* Enters strategic license and development agreement with Biochain on novel, blood-based lung cancer test for China
Read more
Read more
BRIEF-Serodus enters into market making agreement with Norne Securities
* Has entered into a market making agreement with Norne Securities AS with effect from 30 March 2016
Read more
Read more
Tuesday, March 29, 2016
BRIEF-Skyepharma says marketing application for breath-actuated form of Flutiform to be reviewed in Europe
* Partner mundipharma's marketing authorisation application for breath-actuated version of Flutiform accepted for review in europe Source text for Eikon: Further company coverage:
Read more
Read more
BRIEF-Sinclair Pharma sees Q3 revenue to exceed 8 mln stg
* As expected, reported sales at 7.7 mln stg (H1 FY15: 10.5 mln stg) were lower in H1 as a result of planned distributor de-stocking
Read more
Read more
BRIEF-Exiqon to receive takeover offer from QIAGEN
* Said on Tuesday QIAGEN N.V informed it will submit voluntary conditional public takeover offer to buy entire share capital of Exiqon for 18 Danish crowns ($2.73) per share
Read more
Read more
BRIEF-Zosano Pharma implements workforce reduction of 24 employees
* On March 24, 2016, implemented a restructuring initiative which includes a workforce reduction of 24 employees
Read more
Read more
BRIEF-Mirna therapeutics says Q4 net loss of $8.8 million
* Net loss was $8.8 million for q4 of 2015 compared to $4.4 million Source text for Eikon: [ID:http://1.usa.gov/22ZnFjz] Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)
Read more
Read more
BRIEF-Acadia Pharma says FDA panel votes 12 to 2 on benefit-risk profile of its drug for Parkinson's Disease psychosis
* Fda advisory committee votes 12 to 2 that benefits of acadia pharmaceuticals' nuplazid(tm) (pimavanserin) for the treatment of psychosis associated with parkinson's disease outweigh the risks Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
GE to sell $1.4 bln U.S. hotel franchise loan portfolio
March 29 (Reuters) - General Electric Co said it had agreed to sell GE Capital's U.S. hotel franchise loan portfolio to a unit of Western Alliance Bancorp.
Read more
Read more
BRIEF-Argos Therapeutics reports Q4 shr loss of $0.84
* Argos therapeutics reports fourth quarter and full-year 2015 financial results and operational highlights
Read more
Read more
BRIEF-Helix Biopharma Sven Rohmann to step into CEO role, effective immediately
* Zbigniew markowski will be stepping down from his positions as chief executive officer of co, chairman of helix polska
Read more
Read more
BRIEF-Ariad Pharmaceuticals estimates recording $3.3 mln charge related to termination benefits
* As a result of workforce reduction, estimates recording a one-time charge of about $3.3 million related to termination benefits
Read more
Read more
UPDATE 1-Aveo Pharmaceuticals to pay $4 mln to settle kidney drug case
March 29 (Reuters) - Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns about its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday.
Read more
Read more
West Africa Ebola outbreak no longer poses global risk, WHO says
GENEVA, March 29 (Reuters) - West Africa's Ebola outbreak no longer constitutes a threat to international public health, the World Health Organization (WHO) said on Tuesday, declaring an end to a nearly 20-month emergency that has killed about 11,300 people.
Read more
Read more
CORRECTED-Giant rats to sniff out tuberculosis in Tanzania, Mozambique prisons
DAR ES SALAAM, March 29 (Thomson Reuters Foundation) - S cientists in East Africa plan to exploit trained rats' highly developed sense of smell to carry out mass screening for tuberculosis among inmates of crowded prisons in Tanzania and Mozambique.
Read more
Read more
UPDATE 1-Sanofi poaches AstraZeneca scientist as new research head
LONDON, March 29 (Reuters) - French drugmaker Sanofi has poached one of AstraZeneca's top scientists to be its new research head in another high-profile departure for the British drugmaker.
Read more
Read more
BRIEF-Biopharmx announces pricing of public offering to raise $4.3 mln
* Pricing of an underwritten public offering of 3.6 million shares of common stock and warrants to purchase 1.8 shares of common stock
Read more
Read more
Deals of the day- Mergers and acquisitions
March 29 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:
Read more
Read more
UPDATE 1-War in Yemen kills many children, leaves others malnourished - UNICEF
* 61 percent of child casualties caused by Saudi-led strikes (Adds quotes from briefing, new paras 5-6, 14)
Read more
Read more
BRIEF-Oramed Pharmaceuticals says patent granted in India
* Patent granted in India for oral administration of proteins Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
BRIEF-Redhill Biopharma says re-submission of rizaport U.S. NDA expected in Q4 of 2016
* Re-Submission of rizaport U.S. New drug application (NDA) to FDA and receipt of a new pdufa date are expected in Q4 of 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
BRIEF-Concordia Healthcare provides information to correct inaccuracies in recent media report concerning 2015 financial results
* Providing information to correct inaccuracies, misstatements that appeared in recent media report concerning 2015 audited financial results
Read more
Read more
Keryx says anemia drug succeeds in study of kidney patients
March 29 (Reuters) - Keryx Biopharmaceuticals Inc on Tuesday said its drug to treat iron deficiency anemia in chronic kidney disease patients not yet requiring dialysis met the goals of a late stage clinical trial, potentially paving the way for an expanded approval of the treatment.
Read more
Read more
BRIEF-Biosintez FY 2015 net profit to RAS slightly up at 42,000 roubles
* FY 2015 net profit to Russian Accounting Standards (RAS) of 42,000 roubles versus 38,000 roubles year ago
Read more
Read more
BRIEF-BioDue buys 250,000 euro property to expand industrial production
* Said on Friday it bought a property for production purposes for 250,000 euros ($279,675.00)
Read more
Read more
Monday, March 28, 2016
Swiss stocks - Factors to watch on March 29
ZURICH, March 29 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Tuesday:
Read more
Read more
German stocks - Factors to watch on March 29
FRANKFURT, March 29 (Reuters) - The following are some of the factors that may move German stocks on Tuesday:
Read more
Read more
BRIEF-MDxHealth partners with Andros Men's Clinic to offer SelectMDx for prostate cancer
* Mdxhealth partners with Andros Men's Health Clinic to offer SelectMDx for prostate cancer
Read more
Read more
UPDATE 2-Origin withdraws offer to buy Affymetrix
March 28 (Reuters) - Origin Technologies Corp, owned by Affymetrix Inc's former employees, withdrew its offer to buy the gene-sequencing products maker, hours after Affymetrix said on Monday that Origin's raised bid was not superior to Thermo Fisher Scientific Inc's proposal.
Read more
Read more
U.S. lawmakers want health agencies to lower prostate cancer drug cost
March 28 (Reuters) - A group of lawmakers is calling on the National Institutes of Health and Department of Health and Human Services to step in and reduce the cost of Medivation Inc's and Astellas Pharma Inc's prostate cancer drug Xtandi.
Read more
Read more
BRIEF-Rigel Pharmaceuticals says CEO Raul R. Rodriguez FY 2015 total compensation $2.1 mln
* Says CEO Raul R. Rodriguez FY 2015 total compensation $2.1 million versus $1.3 million - SEC filing
Read more
Read more
Origin withdraws offer to buy Affymetrix
March 28 (Reuters) - Origin Technologies Corp, owned by Affymetrix Inc's former employees, withdrew its offer to buy the gene sequencing products maker, hours after Affymetrix said Origin's raised offer was not superior to Thermo Fisher Scientific Inc's proposal.
Read more
Read more
U.S. scientists develop mouse model to test Zika vaccines, drugs
CHICAGO, March 28 (Reuters) - U.S. scientists have identified a genetically modified strain of mice that develop Zika, an important tool needed for testing vaccines and medicines to treat the virus that is rapidly spreading across the Americas and the Caribbean.
Read more
Read more
Affymetrix backs Thermo Fisher deal
March 28 (Reuters) - Gene sequencing products maker Affymetrix Inc said on Monday that a raised offer from its former executives does not constitute a superior proposal and backed its deal to be acquired by Thermo Fisher Scientific Inc.
Read more
Read more
BRIEF-Gilead Sciences says CEO John C. Martin's 2015 total compensation $18.8 mln - SEC Filing
* Says CFO Robin L. Washington FY 2015 total compensation $5.6 million versus $6.2 million in FY 2014 - SEC filing
Read more
Read more
BRIEF-Mylan launches generic Ultram extended-release tablets
* U.S. launch of Tramadol Hydrochloride extended-release tablets USP, 100 mg, 200 mg and 300 mg
Read more
Read more
Saudi Arabian regulator approves Yamamah Steel IPO
DUBAI, March 28 (Reuters) - Saudi Arabia's Capital Market Authority has approved an initial public offer of shares in Al Yamamah Steel Industries Co, the regulator said on Monday, after severe volatility in the stock market earlier this year disrupted listing plans.
Read more
Read more
Valeant CEO subpoenaed to testify before U.S. Senate panel
WASHINGTON, March 28 (Reuters) - The chief executive of Valeant Pharmaceuticals International Inc, which is under scrutiny for dramatically hiking the price of older drugs, has been summoned to testify at a U.S. congressional hearing on April 27, the panel said on Monday.
Read more
Read more
Shire gets favorable ruling against Allergan in Lialda patent case
March 28 (Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020.
Read more
Read more
BRIEF-Eiger Biopharmaceuticals says EMA has granted orphan medicinal product status to ubenimex
* European Medicines Agency (EMA) has granted orphan medicinal product status to ubenimex Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
BRIEF-Inspiremd Q4 non-gaap loss per share $0.31
* Inspiremd reports financial results for the fourth quarter and year ended december 31, 2015
Read more
Read more
UPDATE 1-Alder BioPharma's migraine drug succeeds in mid-stage study
March 28 (Reuters) - Alder BioPharmaceuticals Inc said its drug to prevent migraines met the main goal in a mid-stage study, the results of which support a quarterly single injection dosing strategy.
Read more
Read more
Alder BioPharma's migraine drug succeeds in mid-stage study
March 28 (Reuters) - Alder BioPharmaceuticals Inc said on Monday its drug to prevent migraines had met the main goal in a keenly watched mid-stage study.
Read more
Read more
UPDATE 2-Czechs roll out red carpet for first visit by Chinese president
* Unknown suspect defaces Chinese flags on eve of visit (Adds Chinese Foreign Ministry on flags)
Read more
Read more
Sunday, March 27, 2016
Czechs roll out red carpet for first visit by Chinese president
PRAGUE, March 28 (Reuters) - China's President Xi Jinping begins a two-day state visit to Prague on Monday to promote business ties, crowning efforts by Czech President Milos Zeman to build a strategic relationship with Beijing.
Read more
Read more
Zimmer Biomet shares could rise 25 pct - Barron's
March 27 (Reuters) - Shares of hip, knee and shoulder replacement maker Zimmer Biomet Holdings could rise 25 percent as the market sees signs that the company is recovering from merger indigestion, according to an article in the latest edition of Barron's.
Read more
Read more
Chile reports its first sexually transmitted Zika case
BUENOS AIRES, March 26 (Reuters) - Chile has confirmed its first case of the Zika virus having been sexually transmitted, the health ministry said in a statement on its website on Saturday.
Read more
Read more
Saturday, March 26, 2016
Probe into Biomet bribery charges to continue past DPA deadline
March 25 (Reuters) - Zimmer Biomet Holdings Inc said on Friday a U.S. investigation into foreign bribes at Biomet, before it was acquired by Zimmer, would continue past a deferred prosecution agreement deadline of March 26.
Read more
Read more
Friday, March 25, 2016
UPDATE 2-U.S. urges waiting period before conception after Zika infection
March 25 (Reuters) - U.S. health officials are recommending that women wait at least two months, and men at least six, before attempting to conceive after infection with Zika, a virus linked to thousands of suspected cases of birth defects in Brazil.
Read more
Read more
UPDATE 1-U.S. approves $3.2 bln sale of Boeing P-8A patrol planes to UK
WASHINGTON, March 25 (Reuters) - The U.S. government has approved the sale of up to nine Boeing Co P-8A Poseidon maritime patrol planes to Britain in a deal valued at up to $3.2 billion, the U.S. Defense Department said Friday.
Read more
Read more
BRIEF-Allergan CEO's 2015 total compensation was $21.6 million
* CEO Brenton Saunders' 2015 total compensation was $21.6 million versus $36.6 million in 2014 - SEC filing
Read more
Read more
Sprout investors say Valeant prices 'female Viagra' too high - Bloomberg
March 25 (Reuters) - Investors in Sprout Pharmaceuticals, which makes the first drug to treat low sexual desire in women and was bought by Valeant Pharmaceuticals International Inc last year, say the drug has been priced too high, Bloomberg reported on Friday.
Read more
Read more
U.S. health officials tell couples exposed to Zika to wait to conceive
March 25 (Reuters) - The U.S. Centers for Disease Control and Prevention issued guidelines on Friday recommending how long men and women exposed to the Zika virus should wait before trying to conceive babies.
Read more
Read more
BRIEF-Onxeo closes DNA Therapeutics acquisition
March 25 (Reuters) - Onxeo SA :
* Announces closing of DNA Therapeutics acquisition
Source text for Eikon: Further company coverage:
(Gdynia Newsroom)
Read more
Senate's request for info from Ackman related to Valeant-source
BOSTON, March 25 (Reuters) - U.S. legislators investigating price hikes in the pharmaceutical industry have asked William Ackman's hedge fund for information on Valeant Pharmaceuticals International Inc, according to a person familiar with the matter.
Read more
Read more
BRIEF-FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
* Single pivotal study established statistical evidence that pimavanserin 40 mg does not worsen parkinson's disease status
Read more
Read more
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
March 25 (Reuters) - U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc's drug to treat psychosis associated with Parkinson's disease was effective enough to warrant approval.
Read more
Read more
Thursday, March 24, 2016
UPDATE 2-China says vaccine scandal suspect was free to re-offend
BEIJING, March 24 (Reuters) - The person at the centre of an illegal vaccine scandal in China had been sentenced for similar crimes but was allowed to re-offend after being given a suspended sentence, the head of a food and drug watchdog told a news conference on Thursday.
Read more
Read more
BRIEF- Biodue FY net profit up at EUR 2.4 mln, proposes dividend
* Reported on Thursday its FY net profit of 2.4 million euros ($2.68 million) versus 1.7 million euros a year ago
Read more
Read more
UPDATE 3-Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute
SAN JOSE, Calif.,/NEW YORK, March 24 (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.
Read more
Read more
UPDATE 1-Netflix admits to downgrading video quality on AT&T, Verizon phones - WSJ
March 24 (Reuters) - Netflix Inc said it had been lowering the quality of its video for customers watching its service on wireless networks such as AT&T and Verizon Communications for more than five years, The Wall Street Journal reported on Thursday.
Read more
Read more
PRESS DIGEST- British Business - March 25
March 25 - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Read more
Read more
Netflix admits to downgrading video quality on AT&T, Verizon phones - WSJ
March 24 (Reuters) - Netflix Inc said it had been lowering the quality of its video for customers watching its service on wireless networks such as AT&T and Verizon Communications for more than five years, The Wall Street Journal reported on Thursday.
Read more
Read more
Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute
SAN JOSE, Calif., March 24 (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.
Read more
Read more
Verizon says security breach leads to customer data leak
March 24 (Reuters) - Verizon Communications Inc said an attacker had exploited a security vulnerability on its enterprise client portal to steal contact information of a number of customers.
Read more
Read more
BRIEF-Briacell says Joseph wagner resigned his positions as president and CEO
* Joseph wagner has resigned his positions as president and chief executive officer of company, effective immediately Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Read more
Read more
REFILE-UPDATE 1-Ackman's hedge fund cooperating with U.S. on drug pricing probe -letter
BOSTON, March 24 (Reuters) - Billionaire investor William Ackman, whose hedge fund is one of the biggest investors in drug company Valeant, has been asked to supply information to U.S. legislators probing price hikes in the pharmaceutical industry.
Read more
Read more
Canada will not appeal ruling allowing patients to grow own pot
VANCOUVER, March 24 (Reuters) - Medical marijuana patients in Canada will regain the right to grow their own cannabis after the government said on Thursday it would comply with a federal court decision against a ban introduced by the previous Conservative government.
Read more
Read more
U.S.-based stock funds take in nearly $2 bln in latest week -Lipper
NEW YORK, March 24 (Reuters) - U.S.-based stock funds took in nearly $2 billion in the week ended March 23, Lipper data showed on Thursday, as investors showed a new willingness to buy riskier assets.
Read more
Read more
Handful of nations see many unintended pregnancies despite sex with contraception
NEW YORK, March 24 (Thomson Reuters Foundation) - Nations from Brazil to Egypt and Turkey are among developing countries with the highest rates of contraceptive failure, according to research released on Thursday on unintended pregnancies.
Read more
Read more
BRIEF-Axsome Therapeutics reports Q4 loss per share of $0.12
* "currently anticipates that its cash will be sufficient to fund its anticipated operations into q3 of 2017"
Read more
Read more
BRIEF-Frazier Healthcare VI, L.P. reports 9.07 pct stake in Collegium Pharmaceutical Inc as of May 12, 2015 - SEC filing
* Frazier healthcare VI, L.P. Reports 9.07 pct stake in Collegium Pharmaceutical Inc as of May 12, 2015 - SEC filing Source text (http://1.usa.gov/1ZxgKfr) Further company coverage:
Read more
Read more
Genetic study tracks start of Zika's invasion of Americas back to 2013
LONDON, March 24 (Reuters) - The Zika virus currently sweeping through the Americas looks to have hitched a ride on a plane into Brazil in 2013 and begun its invasion of the continent from there, scientists said on Thursday.
Read more
Read more
CBO says ACA insurance provisions to cost $660 bln net in 2016
WASHINGTON, March 24 (Reuters) - Federally subsidized health insurance coverage provided under President Barack Obama's Affordable Care Act will cost the U.S. government a net $660 billion in 2016, the U.S. Congressional Budget Office said on Thursday.
Read more
Read more
SteamBroker
Что такое "SteamBroker"?
Сервис SteamBroker предоставляет площадку для торговли вещами из сервиса цифровой дистрибуции Steam. На нашей площадке вы можете купить у других пользователей или продать сами любые предметы из Вашего инвентаря, которые возможно передать через торговое предложение Steam. Например, вещи из таких игр как Dota™ 2, Counter Strike: Global Offensive™ (CS:GO), Team Fortress™ 2, H1Z1 и прочих. А так же возможна продажа коллекционных карточек Steam и даже игр, в виде подарков в инвентаре, которые так же возможно передавать. Вы можете купить вещи за ту цену, которую указывают другие пользователи, что гарантирует отличные цены без лишних наценок.
Так же Вы можете использовать наш сайт как магазин для своих предметов. Вы получите персональную ссылку которая будет отображать только Ваши предметы.
Наш сервис гарантирует абсолютную безопасность всех сделок. Товары передаются через наши сервисные аккаунты Steam, которые выступают в качестве гаранта и контролируют точность получения вещей покупателем и выплату денег продавцу.
Перейти на SteamBroker
BRIEF-Camber Capital reports 14.54% stake in Sequenom Inc
March 24 (Reuters) - Camber Capital Management LLC Reports 14.54% Stake In Sequenom Inc As Of March 23, 2016
Read more
Read more
Subscribe to:
Posts (Atom)